# Junjie Kuang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/junjie-kuang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 582 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 8 |
| i10-index | 8 |
| Last Known Institution | Liuzhou General Hospital |
| OpenAlex ID | https://openalex.org/A5075582658 |
| ORCID iD | 0000-0001-8587-5065 |
| Works | 18 |

## Researcher papers

- [Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer](https://scholariq.org/papers/development-and-interpretation-of-a-pathomics-based-model-for-the-prediction-of/)
- [Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6](https://scholariq.org/papers/cancer-associated-fibroblasts-induce-growth-and-radioresistance-of-breast-cancer/)
- [NUCKS1 Promotes Proliferation, Invasion and Migration of Non-Small Cell Lung Cancer by Upregulating CDK1 Expression](https://scholariq.org/papers/nucks1-promotes-proliferation-invasion-and-migration-of-non-small-cell-lung/)
- [Radiomics-based nomogram using CT imaging for noninvasive preoperative prediction of early recurrence in patients with hepatocellular carcinoma](https://scholariq.org/papers/radiomics-based-nomogram-using-ct-imaging-for-noninvasive-preoperative/)
- [Smoking Exposure and Survival of Patients with Esophagus Cancer: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/smoking-exposure-and-survival-of-patients-with-esophagus-cancer-a-systematic/)
- [Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials](https://scholariq.org/papers/efficacy-of-adding-bevacizumab-in-the-first-line-chemotherapy-of-metastatic/)
- [Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer](https://scholariq.org/papers/machine-learning-analysis-reveals-tumor-heterogeneity-and-stromal-immune-niches/)
- [Optimizing mitochondria function in immune cells: implications for cancer immunotherapy](https://scholariq.org/papers/optimizing-mitochondria-function-in-immune-cells-implications-for-cancer/)
- [Efficacy of sorafenib combined with transcatheter hepatic arterial chemoembolization in treating intermediate-advanced hepatocellular carcinoma.](https://scholariq.org/papers/efficacy-of-sorafenib-combined-with-transcatheter-hepatic-arterial/)
- [A transferrable and interpretable multiple instance learning model for microsatellite instability prediction based on histopathology images](https://scholariq.org/papers/a-transferrable-and-interpretable-multiple-instance-learning-model-for/)
- [Differential gene expression profiling and machine learning-based discovery of key genetic markers in VTE and CKD](https://scholariq.org/papers/differential-gene-expression-profiling-and-machine-learning-based-discovery-of/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)

## Researcher university

- [Liuzhou General Hospital](https://scholariq.org/institutions/liuzhou-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.